---
category: news
title: "bluebird (BLUE) Down Despite FDA Nod to Gene Therapy for SCD"
excerpt: "SCD is a group of inherited blood disorders affecting approximately 100,000 people in the United States. It is a complex and progressive genetic disease that generally leads to un"
publishedDateTime: 2023-12-11T15:07:00Z
originalUrl: "https://www.nasdaq.com/articles/bluebird-blue-down-despite-fda-nod-to-gene-therapy-for-scd"
webUrl: "https://www.nasdaq.com/articles/bluebird-blue-down-despite-fda-nod-to-gene-therapy-for-scd"
type: article
quality: 49
heat: 49
published: false

provider:
  name: Nasdaq
  domain: nasdaq.com

topics:
  - AI in Healthcare
  - AI

secured: "8T2A6l8CW2Xk8ZAv38VyQIol52kQss7rUAe2km+4l0uH00NMhNC5RFZyZ4VO902uu7k97I1eAWJSEsa+cMac2D6DFfgOcFW7XZKI17BFiejQSc9uTgUOAOdPiWYidp1KGHPdRqBE44h4Zn6i5qrIr0YPxt7izgLnyR8UwJqLPiY5R7ND1uYWPCRc+Ze7jwKGZJ9OnskrQqrKnbRiiIIlAItV34g0OLnZzyCWkuIDBG9KqGwP101cFbfdAQwtPreLBU/bQun/ajM9vxt7NaKjfrYHZjGTDX639odMyV8tbfuIhyLAkY6fds0hkhYaUYe+GIrZswuY0N+sNfF1M9ifxkGI6fpM6LNHQfJQMQCFSWU=;hmBf50EzXgEqdThedBfWJA=="
---

